Synonym: (5R,6S,8R,2′R)-2-(2′-tetrahydrofuryl)-6-hydroxyethylpenem-3-carboxylate sodium salt; ALP 201; Farom; Fropenem; Furopenem; SUN 5555; SY 5555; Wy 49605
CAS Number: 122547-49-3 (anhydrous)
Empirical Formula (Hill Notation): C12H14NNaO5S · xH2O
Molecular Weight: 307.30 (anhydrous basis)
MDL Number: MFCD17215925
Linear Formula: C12H14NNaO5S · xH2O
Product Type: Chemical
| assay |
≥98% (HPLC) |
| color |
white to light brown |
| form |
powder |
| InChI |
1S/C12H15NO5S.Na.H2O/c1-5(14)7-10(15)13-8(12(16)17)9(19-11(7)13)6-3-2-4-18-6;;/h5-7,11,14H,2-4H2,1H3,(H,16,17);;1H2/q;+1;/p-1/t5-,6-,7+,11-;;/m1../s1 |
| InChI key |
FHSVCMPZCIOKGW-VIDQLUEFSA-M |
| optical activity |
[α]/D +120 to +130°, c = 1.0 in water |
| originator |
Daiichi-Sankyo |
| Quality Level |
100  |
| SMILES string |
O.[Na+].C[C@@H](O)C1C2SC(C3CCCO3)=C(N2C1=O)C([O-])=O |
| solubility |
H2O: ≥20 mg/mL |
| storage condition |
desiccated |
| storage temp. |
−20°C |
| Biochem/physiol Actions: |
Broad spectrum beta-lactam antibiotic belonging to the penem group; β-lactamase stable. |
| Biochem/physiol Actions: |
Faropenem sodium is an ultra-broad spectrum, β-lactamase resistant, β-lactam antibiotic active against both Gram-positive and Gram-negative bacteria. |
| Features and Benefits: |
This compound was developed by Daiichi-Sankyo . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| General description: |
Faropenem sodium hydrate belongs to the penem group of antibiotics prescribed for oral usage. Enterobacteriaceae bacterial infections with cephalosporin resistance are susceptible to faropenem. Faropenem could be an effective antibiotic to treat urinary tract infections caused by extended-spectrum beta-lactamases (ESBL) producing bacteria. |
| Packaging: |
10, 50 mg in glass bottle |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
−20°C |
| UNSPSC |
12352200 |
